Hims & Hers Health, Inc. (HIMS) Insider Trading

Last 12 months

Insiders bought $1.17M and sold $19.4M on the open market.

99% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−$18.2M

1 buy · 43 sales

Under a 10b5-1 plan

99%

of the value sold

Insiders who bought / sold

1 / 8

executives and directors

Last open-market buy

May 2026

May 26, 2026

Get an email when HIMS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 14	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	3,461	$29.06	$101k	1.2%	Form 4
Oct 1	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	2,000	$29.70	$59k	0.8%	Form 4
Sep 30	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	3,461	$29.17	$101k	1.1%	Form 4
Sep 22	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	29,277	$29.95	$877k	11%	Form 4
Sep 17	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	12,313	$28.82	$355k	4.5%	Form 4
Sep 16	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	6,236	$27.86	$174k	2.0%	Form 4
Sep 15	Mohamed Elshenawy CTO	Sold10b5-1 plan	7,954	$28.39	$226k	4.1%	Form 4
Sep 15	Michael Chi Chief Operating Officer	Sold10b5-1 plan	14,027	$28.39	$398k	3.0%	Form 4
Sep 2	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	3,458	$28.33	$98k	1.1%	Form 4
Aug 19	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	4,938	$29.99	$148k	1.8%	Form 4
Aug 19	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	25,111	$27.55	$692k	7.4%	Form 4
Aug 18	Deborah M. Autor Chief Policy Officer	Sold10b5-1 plan	16,773	$27.85	$467k	26%	Form 4
Jun 18 – Aug 17	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan 2 parts	64,771	$34.05 average	$2.21M	20%	Form 4
Jul 17	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	7,163	$31.99	$229k	2.4%	Form 4
Jul 6	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	7,163	$36.49	$261k	2.4%	Form 4
Jun 22	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	18,197	$34.03	$619k	5.9%	Form 4
Jun 18	Patrick Harrison Carroll Chief Medical Officer	Sold10b5-1 plan	23,726	$35.00	$830k	12%	Form 4
Jun 17	Michael Chi Chief Operating Officer	Sold10b5-1 plan	14,027	$31.50	$442k	3.1%	Form 4
Jun 16 – 17	Irene Becklund PAO	Sold10b5-1 plan 2 parts	12,063	$30.72 average	$371k	64%	Form 4
Jun 17	Mohamed Elshenawy CTO	Sold10b5-1 plan	30,040	$31.50	$946k	23%	Form 4
May 26	David B Wells Director	Bought	48,400	$24.24	$1.17M	27%	Form 4
May 18	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	7,950	$23.64	$188k	2.9%	Form 4
Apr 20	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	19,645	$29.96	$589k	6.8%	Form 4
Apr 20	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	9,463	$30.00	$284k	3.1%	Form 4
Apr 16 – 17	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan 2 parts	54,927	$26.53 average	$1.46M	17%	Form 4
Apr 6	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	3,975	$19.98	$79k	1.2%	Form 4
Mar 20	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	9,217	$23.77	$219k	2.7%	Form 4
Mar 17	Michael Chi Chief Operating Officer	Sold10b5-1 plan	97,289	$24.69	$2.4M	19%	Form 4
Mar 17	Irene Becklund PAO	Sold10b5-1 plan	5,529	$24.69	$137k	39%	Form 4
Mar 17	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	4,812	$24.69	$119k	1.5%	Form 4
Feb 27	Soleil Boughton Chief Legal Officer	Sold10b5-1 plan	4,651	$15.21	$71k	1.0%	Form 4
Feb 3	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	5,262	$26.44	$139k	5.0%	Form 4
Jan 20	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	9,067	$30.34	$275k	8.4%	Form 4
Jan 5	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	9,070	$33.79	$306k	8.4%	Form 4
Dec 22, 2025	Oluyemi Okupe Chief Financial Officer	Sold10b5-1 plan	23,090	$35.72	$825k	18%	Form 4
Dec 17, 2025	Michael Chi Chief Operating Officer	Sold10b5-1 plan	13,750	$36.71	$505k	4.3%	Form 4
Dec 17, 2025	Irene Becklund PAO	Sold10b5-1 plan	8,411	$36.71	$309k	80%	Form 4
Dec 17, 2025	Deborah M. Autor Chief Policy Officer	Sold10b5-1 plan	7,054	$36.71	$259k	53%	Form 4
Dec 17, 2025	Patrick Harrison Carroll Chief Medical Officer	Sold10b5-1 plan	10,021	$36.71	$368k	5.6%	Form 4
Dec 9, 2025	Garcia Andrea G Perez Director	SoldNo plan	2,500	$39.17	$98k	3.0%	Form 4

Oct 1410b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 3,461 at $29.06
$101k
1.2% of stake
Oct 110b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 2,000 at $29.70
$59k
0.8% of stake
Sep 3010b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 3,461 at $29.17
$101k
1.1% of stake
Sep 2210b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 29,277 at $29.95
$877k
11% of stake
Sep 1710b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 12,313 at $28.82
$355k
4.5% of stake
Sep 1610b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 6,236 at $27.86
$174k
2.0% of stake
Sep 1510b5-1 plan
Mohamed Elshenawy
CTO · sold 7,954 at $28.39
$226k
4.1% of stake
Sep 1510b5-1 plan
Michael Chi
Chief Operating Officer · sold 14,027 at $28.39
$398k
3.0% of stake
Sep 210b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 3,458 at $28.33
$98k
1.1% of stake
Aug 1910b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 4,938 at $29.99
$148k
1.8% of stake
Aug 1910b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 25,111 at $27.55
$692k
7.4% of stake
Aug 1810b5-1 plan
Deborah M. Autor
Chief Policy Officer · sold 16,773 at $27.85
$467k
26% of stake
Jun 18 – Aug 1710b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 64,771 at avg $34.05
$2.21M
20% of stake
Jul 1710b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 7,163 at $31.99
$229k
2.4% of stake
Jul 610b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 7,163 at $36.49
$261k
2.4% of stake
Jun 2210b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 18,197 at $34.03
$619k
5.9% of stake
Jun 1810b5-1 plan
Patrick Harrison Carroll
Chief Medical Officer · sold 23,726 at $35.00
$830k
12% of stake
Jun 1710b5-1 plan
Michael Chi
Chief Operating Officer · sold 14,027 at $31.50
$442k
3.1% of stake
Jun 16 – 1710b5-1 plan
Irene Becklund
PAO · sold 12,063 at avg $30.72
$371k
64% of stake
Jun 1710b5-1 plan
Mohamed Elshenawy
CTO · sold 30,040 at $31.50
$946k
23% of stake
May 26
David B Wells
Director · bought 48,400 at $24.24
$1.17M
27% of stake
May 1810b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 7,950 at $23.64
$188k
2.9% of stake
Apr 2010b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 19,645 at $29.96
$589k
6.8% of stake
Apr 2010b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 9,463 at $30.00
$284k
3.1% of stake
Apr 16 – 1710b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 54,927 at avg $26.53
$1.46M
17% of stake
Apr 610b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 3,975 at $19.98
$79k
1.2% of stake
Mar 2010b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 9,217 at $23.77
$219k
2.7% of stake
Mar 1710b5-1 plan
Michael Chi
Chief Operating Officer · sold 97,289 at $24.69
$2.4M
19% of stake
Mar 1710b5-1 plan
Irene Becklund
PAO · sold 5,529 at $24.69
$137k
39% of stake
Mar 1710b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 4,812 at $24.69
$119k
1.5% of stake
Feb 2710b5-1 plan
Soleil Boughton
Chief Legal Officer · sold 4,651 at $15.21
$71k
1.0% of stake
Feb 310b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 5,262 at $26.44
$139k
5.0% of stake
Jan 2010b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 9,067 at $30.34
$275k
8.4% of stake
Jan 510b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 9,070 at $33.79
$306k
8.4% of stake
Dec 22, 202510b5-1 plan
Oluyemi Okupe
Chief Financial Officer · sold 23,090 at $35.72
$825k
18% of stake
Dec 17, 202510b5-1 plan
Michael Chi
Chief Operating Officer · sold 13,750 at $36.71
$505k
4.3% of stake
Dec 17, 202510b5-1 plan
Irene Becklund
PAO · sold 8,411 at $36.71
$309k
80% of stake
Dec 17, 202510b5-1 plan
Deborah M. Autor
Chief Policy Officer · sold 7,054 at $36.71
$259k
53% of stake
Dec 17, 202510b5-1 plan
Patrick Harrison Carroll
Chief Medical Officer · sold 10,021 at $36.71
$368k
5.6% of stake
Dec 9, 2025No plan
Garcia Andrea G Perez
Director · sold 2,500 at $39.17
$98k
3.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HIMS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Offices & Clinics of Doctors of Medicine

TDOCTeladoc Health Inc.

GDRXGoodRx Holdings, Inc.

DOCSDoximity Inc.

LFMDLifeMD Inc.

AMWLAmerican Well Corporation

OSCROscar Health, Inc.

Spot a number that looks wrong? Check it in HIMS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HIMS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.